 |
인쇄하기
취소
|
Kwangdong to develop a new anti-leukemia drug.
Kwangdong pharmaceutical company announced to develop a new mono-clonal antibody for the treatment of leukemia with the research team of SNU Medical College and Dinona, an antibody research company.
The technology of the mono clonal antibody therapy was aimed at a new therapeutic approach for acute leukemia and a some of lymphoma, which was developed jointly by the research team of SNU medic...
The technology of the mono clonal antibody therapy was aimed at a new therapeutic approach for acute leukemia and a some of lymphoma, which was developed jointly by the research team of SNU medic...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.